References
- MozaffariehMFlammerJNew insights in the pathogenesis and treatment of normal tension glaucomaCurr Opin Pharmacol2013131434923092679
- BurgoyneCFDownsJCPremise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve headJ Glaucoma200817431832818552618
- [No authors listed]Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study GroupAm J Ophthalmol199812644874979780093
- BeanGWCamrasCBCommercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differencesSurv Ophthalmol200853Suppl 1S69S8419038626
- DubinerHBNoeckerRSustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%Clin Ophthalmol2012652553122536047
- SeiboldLKKahookMYThe diurnal and nocturnal effect of travoprost with sofZia on intraocular pressure and ocular perfusion pressureAm J Ophthalmol201415714449.e124182742
- InoueKIwasaMWakakuraMTomitaGEffects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucomaClin Ophthalmol201261315131922969276
- SuhMHParkKHKimDMEffect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucomaJpn J Ophthalmol2009531182319184304
- AngGSKerseyJPShepstoneLBroadwayDCThe effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trialBr J Ophthalmol20089281129113318511540
- QuarantaLKatsanosARussoARivaI24-hour intraocular pressure and ocular perfusion pressure in glaucomaSurv Ophthalmol2013581264123217586
- KrupinTLiebmannJMGreenfieldDSRitchRGardinerSLow-Pressure Glaucoma Study GroupA randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment StudyAm J Ophthalmol2011151467168121257146
- QuarantaLGandolfoFTuranoREffects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucomaInvest Ophthalmol Vis Sci20064772917292316799034
- NomuraYNakakuraSMoriwakiMTakahashiYShirakiKEffect of travoprost on 24-hour intraocular pressure in normal tension glaucomaClin Ophthalmol2010464364720689776
- StewartWCHolmesKTJohnsonMAWashout periods for brimonidine 0.2% and latanoprost 0.005%Am J Ophthalmol2001131679879911384581
- TraversoCERopoAPapadiaMUusitaloHA phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprostJ Ocul Pharmacol Ther2010269710420148656
- GrossRLPeaceJHSmithSEDuration of IOP reduction with travoprost BAK-free solutionJ Glaucoma20081721722218414108
- SitAJWeinrebRNCrowstonJGKripkeDFLiuJHSustained effect of travoprost on diurnal and nocturnal intraocular pressureAm J Ophthalmol20061411131113316765686
- QuarantaLPizzolanteTRivaIHaidichABKonstasAGStewartWCTwenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucomaBr J Ophthalmol2008921227123118586898
- LiuCJKoYCChengCYChanges in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patientsOphthalmology20021092241224712466165
- IshibashiSHiroseNTawaraAKubotaTEffect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucomaJ Glaucoma20061535435716988595